newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

ZURICH, SWITZERLAND – June 18, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today announced that the Company has generated new in vitro proof-of-concept data